Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health

You can search in the form below for information related to drugs including Subsidy percentage

Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R06AB52	HISTAMED-F	G	Dexchlorpheniramine maleate - 2mg, Dexamethasone - 0.25mg, Fluphenazine HCl - 0.25mg		Tablet, coated	579,772 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 1g	1g	Injectable powder for solution	38,763,115 L.L
B02BB01	HAEMOCOMPLETTAN P	BioHuman	Fibrinogen, human - 2g	2g	Injectable powder for solution	77,527,404 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 60mg/0.4ml	60mg/0.4ml	Injectable solution	441,042,377 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 30mg/ml	30mg/ml	Injectable solution	224,585,721 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 150mg/ml	150mg/ml	Injectable solution	716,437,779 L.L
B02BX06	HEMLIBRA	BioTech	Emicizumab - 105mg/0.7ml	105mg/0.7ml	Injectable solution	577,741,643 L.L
J05AP51	HARVONI	B	Ledipasvir - 90mg, Sofosbuvir - 400mg		Tablet, film coated	973,113,199 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
L01FD01	HERZUMA	BioTech	Trastuzumab - 440mg	440mg	Injectable powder for concentrate for solution	89,170,219 L.L
L01FD01	HERZUMA	BioTech	Trastuzumab - 150mg	150mg	Injectable powder for concentrate for solution	36,112,482 L.L
L01XX41	HALAVEN	B	Eribulin mesylate - 0.88mg/2ml	0.88mg/2ml	Injectable solution	36,967,093 L.L
L04AB04	HYRIMOZ	BioTech	Adalimumab - 40mg	40mg	Injectable solution	26,715,144 L.L
L04AB04	HYRIMOZ	BioTech	Adalimumab - 40mg	40mg	Injectable solution	26,715,144 L.L